Day: May 17, 2018

The DSA research tool focuses on the transcriptome of a person disease.

This gives researchers with all the information required to pull meaningful conclusions from their experimental data. The Colorectal Malignancy DSA research tool includes 61,528 probesets covering 52,306 colorectal expressed transcripts: 21,968 are present in the human RefSeq database 26,676 of transcripts aren’t within the human RefSeq database 7 percent of this content represents expressed antisense transcripts to annotated genes To date, Almac Diagnostics has launched Colorectal Cancers DSA and Breast Cancer DSA. In June Lung Malignancy DSA will be launched, and Ovarian Cancer DSA and Prostate Tumor DSA will be released later this year. Read More